跳至主要内容
临床试验/CTRI/2009/091/000799
CTRI/2009/091/000799Other3 期

A Randomized, Two Arm, Open Label, Active Controlled, Multicentric Clinical Study to Evaluate the Efficacy and Safety of a Topical Solution of Diclofenac (2.32% w/v) in comparison with Diclofenac Topical Gel (1.16% w/w) in Acute Painful Musculoskeletal Conditions.

Troikaa Pharmaceuticals Limited0 个研究点目标入组 250 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
Other
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Male or females patients aged 18- 70 years.
  • 2.Patients with acute low back ache (non- specific) or pain and inflammation following trauma to muscles/ tendons/ ligaments/ joints (due to strains, sprains, stress, soft tissue injuries or blunt sports injuries) for not more than 2 days.
  • 3.Patients with at least moderate pain of VAS greater than or equals to 4

排除标准

  • 1.Patients below 18 years or above 70 years of age.
  • 2.Hypersensitivity to aspirin/ NSAID or any other component of the formulation
  • 3.Any contraindication to diclofenac / NSAIDs
  • 4.Patients with skin wounds, open injuries or other conditions of broken skin at the site of proposed application
  • 5.Concomitant skin disease at site of application
  • 6.Use of another topical product at application site
  • 7.Pregnant women and lactating mothers
  • 8.Women of child bearing age not practicing or not willing to use contraceptive
  • 9.Unwilling patients.
  • 10.Patients already on oral NSAIDs/ analgesics.
  • 11.Patients requiring hospitalization or other treatment for pain.

研究者

相似试验